appo@xmu.edu.cn
HOME
BROWSE
By ADRs
By Drugs
TOOL
ADR Similarity Search
Structure Similarity Search
DOWNLOAD
HELP
Adverse Drug Reaction Classification System
For ADR
For Drug
Search
----------All----------
ADR Term
ADReCS ID
MedDRA Code
MeSH ID
Drug Name
Drug ID
ATC Code
DrugBank ID
KEGG ID
PubChem ID
CAS RN
Molecular Formula
QuickSearch
Fuzzy Search
Accurate Search
ADR Ontology
ADR Term
Ototoxicity
ADR ID
BADD_A03234
ADR Hierarchy
04
Ear and labyrinth disorders
04.03
Aural disorders NEC
04.03.01
Ear disorders NEC
04.03.01.004
Ototoxicity
12
Injury, poisoning and procedural complications
12.03
Exposures, chemical injuries and poisoning
12.03.01
Poisoning and toxicity
12.03.01.012
Ototoxicity
Description
Not Available
MedDRA Code
10033109
MeSH ID
Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Not Available
Synonym
Ototoxicity | Toxic labyrinthitis | Vestibular toxicity | Cochlear toxicity
Drugs Leading to the ADR
Drug ID
Drug Name
ADR Frequency (FAERS)
ADR Severity Grade (FAERS)
BADD_D00103
Amikacin
0.000414%
BADD_D00104
Amikacin sulfate
-
-
BADD_D00129
Amoxicillin
0.000005%
BADD_D00260
Betamethasone
-
-
BADD_D00351
Capreomycin sulfate
-
-
BADD_D00364
Carboplatin
0.002406%
BADD_D00417
Cetirizine
-
-
BADD_D00418
Cetirizine hydrochloride
-
-
BADD_D00474
Cisplatin
0.001298%
BADD_D00480
Clarithromycin
0.000335%
BADD_D00594
Deferasirox
-
-
BADD_D00596
Deferoxamine
0.002478%
BADD_D00643
Diamminedichloroplatinum
-
-
BADD_D00699
Docetaxel
-
-
BADD_D00804
Erythromycin
0.000267%
BADD_D00806
Erythromycin lactobionate
-
-
BADD_D00975
Framycetin
-
-
BADD_D00979
Furosemide
0.000028%
BADD_D00981
Gabapentin
-
-
BADD_D01226
Kanamycin
-
-
BADD_D01295
Linezolid
0.001647%
BADD_D01449
Metronidazole
0.000066%
BADD_D01552
Neomycin sulfate
-
-
BADD_D01633
Oxaliplatin
0.000336%
BADD_D01653
Paclitaxel
-
-
BADD_D02051
Sodium thiosulfate
-
-
BADD_D02071
Streptomycin
0.000060%
BADD_D02072
Streptomycin sulfate
-
-
BADD_D02105
Tacrolimus
0.000446%
BADD_D02203
Thiotepa
-
-
The 1th Page
1
2
Next
Last
Total 2 Pages
ADReCS-Target
ADR Term
Drug Name
Target